We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+4.16%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$8.11B
AUM Growth
+$714M
Cap. Flow
+$502M
Cap. Flow %
6.18%
Top 10 Hldgs %
12.42%
Holding
1,969
New
224
Increased
1,142
Reduced
504
Closed
91

Top Sells

Rank Stock Value
1
SNN icon
Smith & Nephew
SNN
+$18.2M
2
IBM icon
IBM
IBM
+$11.4M
3
HSBC icon
HSBC
HSBC
+$8.2M
4
THI
TIM HORTONS INC COM, CANADA
THI
+$7.14M
5
SNY icon
Sanofi
SNY
+$6.72M

Sector Composition

Rank Sector Weight
1 Financials 17.68%
2 Healthcare 14.41%
3 Technology 14.21%
4 Industrials 9.02%
5 Consumer Staples 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAJ
51
DELISTED
Canon, Inc.
CAJ
$29.2M 0.36%
921,470
+352,654
+62% +$11.1M
ADP icon
52
Automatic Data Processing
ADP
$109B
$28.1M 0.35%
337,213
-68,328
-17% -$5.54M
ABBV icon
53
AbbVie
ABBV
$465B
$28M 0.35%
428,260
+30,791
+8% +$1.94M
AZN icon
54
AstraZeneca
AZN
$269B
$27.8M 0.34%
395,162
-21,155
-5% -$1.51M
AXP icon
55
American Express
AXP
$224B
$27.6M 0.34%
296,710
+3,820
+1% +$342K
PM icon
56
Philip Morris
PM
$309B
$27.3M 0.34%
334,649
+7,896
+2% +$678K
BMY icon
57
Bristol-Myers Squibb
BMY
$129B
$27.2M 0.34%
460,420
+36,340
+9% +$2.05M
CELG
58
DELISTED
Celgene Corp
CELG
$27.2M 0.33%
242,908
+21,693
+10% +$2.29M
NVO
59
Novo Nordisk
NVO
$228B
$27M 0.33%
1,277,326
+19,502
+2% +$436K
NKE icon
60
Nike
NKE
$64.1B
$27M 0.33%
561,396
+26,324
+5% +$1.23M
BNS icon
61
Scotiabank
BNS
$105B
$26.5M 0.33%
489,616
+150,089
+44% +$8.45M
KMB icon
62
Kimberly-Clark
KMB
$37.6B
$26.2M 0.32%
227,107
+30,516
+16% +$3.39M
SLB icon
63
SLB Ltd
SLB
$72.7B
$26M 0.32%
303,916
-30,261
-9% -$2.78M
MDT icon
64
Medtronic
MDT
$112B
$25.9M 0.32%
359,052
+13,381
+4% +$930K
CHT icon
65
Chunghwa Telecom
CHT
$33.5B
$25.7M 0.32%
872,813
+103,207
+13% +$3.08M
COP icon
66
ConocoPhillips
COP
$144B
$25.4M 0.31%
367,719
+24,415
+7% +$1.7M
NTT
67
DELISTED
Nippon Telegraph & Telephone
NTT
$25.1M 0.31%
978,424
+168,165
+21% +$4.72M
MA icon
68
Mastercard
MA
$498B
$25M 0.31%
290,275
+8,922
+3% +$728K
BA icon
69
Boeing
BA
$169B
$24.1M 0.3%
185,245
+12,770
+7% +$1.62M
BIIB icon
70
Biogen
BIIB
$30.9B
$23.9M 0.29%
70,372
+3,310
+5% +$1.07M
GS icon
71
Goldman Sachs
GS
$289B
$23.9M 0.29%
123,075
+12,191
+11% +$2.29M
COST icon
72
Costco
COST
$432B
$23.7M 0.29%
167,038
+10,552
+7% +$1.43M
CL icon
73
Colgate-Palmolive
CL
$74.8B
$23.4M 0.29%
338,108
+24,633
+8% +$1.66M
TRV icon
74
Travelers Companies
TRV
$81.1B
$23.4M 0.29%
220,946
+24,165
+12% +$2.44M
TFCFA
75
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$23.3M 0.29%
605,822
+32,018
+6% +$1.13M

Similar funds

Aperio Group's Q4 2014 Portfolio in Review

As of Q4 2014, Aperio Group held 1,969 positions worth $8.11B, up 9.7% from $7.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Aperio Group deployed $502M of net new capital in Q4 2014, opening 224 new positions and adding to 1,142 existing holdings. Its largest new stake was USB AG (NEW): 602,727 shares worth $9.96M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Smith & Nephew, an estimated $18.2M trimmed.

  • Aperio Group's largest Q4 2014 buy was USB AG (NEW): 602,727 shares worth $9.96M.
  • Aperio Group added most to Procter & Gamble in Q4 2014, an estimated $14.9M increase.
  • Aperio Group's biggest Q4 2014 reduction was Smith & Nephew, cutting an estimated $18.2M.
  • Aperio Group fully exited TIM HORTONS INC COM, CANADA in Q4 2014, selling an estimated $7.14M.
  • Aperio Group's ten largest holdings make up 12% of its $8.11B portfolio in Q4 2014.
  • Aperio Group opened 224 new positions and closed 91 in Q4 2014.
  • Aperio Group's portfolio value rose 9.7% quarter-over-quarter to $8.11B.

Based on Aperio Group's 13F filing for Q4 2014, filed 30 Jan 2015.